Home >> Research Area >>Metabolism>>SCD>> MK-8245 Trifluoroacetate

MK-8245 Trifluoroacetate

CAS# 1415559-41-9

MK-8245 Trifluoroacetate

Catalog No. BCC1769----Order now to get a substantial discount!

Product Name & Size Price Stock
MK-8245 Trifluoroacetate: 5mg $138 In Stock
MK-8245 Trifluoroacetate: 10mg Please Inquire In Stock
MK-8245 Trifluoroacetate: 20mg Please Inquire Please Inquire
MK-8245 Trifluoroacetate: 50mg Please Inquire Please Inquire
MK-8245 Trifluoroacetate: 100mg Please Inquire Please Inquire
MK-8245 Trifluoroacetate: 200mg Please Inquire Please Inquire
MK-8245 Trifluoroacetate: 500mg Please Inquire Please Inquire
MK-8245 Trifluoroacetate: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of MK-8245 Trifluoroacetate

Number of papers citing our products

Chemical structure

MK-8245 Trifluoroacetate

3D structure

Chemical Properties of MK-8245 Trifluoroacetate

Cas No. 1415559-41-9 SDF Download SDF
PubChem ID 66577003 Appearance Powder
Formula C19H17BrF4N6O6 M.Wt 581.27
Type of Compound N/A Storage Desiccate at -20°C
Solubility Soluble in DMSO
Chemical Name 2-[5-[3-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]-1,2-oxazol-5-yl]tetrazol-2-yl]acetic acid;2,2,2-trifluoroacetic acid
SMILES C1CN(CCC1OC2=C(C=CC(=C2)F)Br)C3=NOC(=C3)C4=NN(N=N4)CC(=O)O.C(=O)(C(F)(F)F)O
Standard InChIKey LEBPCMXFQYATAK-UHFFFAOYSA-N
Standard InChI InChI=1S/C17H16BrFN6O4.C2HF3O2/c18-12-2-1-10(19)7-13(12)28-11-3-5-24(6-4-11)15-8-14(29-22-15)17-20-23-25(21-17)9-16(26)27;3-2(4,5)1(6)7/h1-2,7-8,11H,3-6,9H2,(H,26,27);(H,6,7)
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of MK-8245 Trifluoroacetate

DescriptionMK-8245 trifluoroacetate is a liver-targeting inhibitor of stearoyl-CoA desaturase (SCD) with IC50 of 1 nM for human SCD1 and 3 nM for both rat SCD1 and mouse SCD1, with anti-diabetic and anti-dyslipidemic efficacy. IC50 value: 1 nM (hSCD1) [1] Target: SCD1 in vitro: MK-8245, a phenoxy piperidine isoxazole derivative, has been identified as a potent and liver-specific SCD inhibitor. It contains a tetrazole acetic acid moiety, which is the key molecule for OATPs recognition and liver-targeting. MK-8245 displays similar potencies against human, rat and mouse SCD1 with IC50 values of 1 nM for human SCD1 and 3 nM for both rat SCD1 and mouse SCD1. MK-8245 exhibits a significant SCD inhibition in the rat hepatocyte assay which contains functional, active OATPs with IC50 of 68 nM, while being only weakly active in the HepG2 cell assay which is devoid of active OATPs with IC50 of ~1 μM. MK-8245 displays highly selective activity for the Δ-5 and Δ-6 desaturases (i.e., >100000 μM vs rat and human Δ5D and Δ6D as assessed in the HepG assay [1]. in vivo: Administration of MK-8245 at 10 mg/kg in mice exhibits a tissue distribution profile concentrated in the liver. It shows a liver-to-Harderian gland ratio of 21, suggesting a high degree of liver-targeting compared to a systemically distributed compound with liver-to-Harderian gland ratio of 1.5. Oral dosing of MK-8245 in mice, rats, dogs, and rhesus monkeys demonstrates that MK-8245 is distributed mainly to the liver, with low exposure in tissues associated with potential adverse events. The liver-to-skin ratios are >30:1 in all four species. Administration of MK-8245 to eDIO mice before the glucose challenge improves glucose clearance in a dose-dependent manner with ED50 of 7 mg/kg.

References:
[1]. Oballa RM, et al. Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.J Med Chem. 2011 Jul 28;54(14):5082-96. Epub 2011 Jun 28.

MK-8245 Trifluoroacetate Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

MK-8245 Trifluoroacetate Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of MK-8245 Trifluoroacetate

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 1.7204 mL 8.6019 mL 17.2037 mL 34.4074 mL 43.0093 mL
5 mM 0.3441 mL 1.7204 mL 3.4407 mL 6.8815 mL 8.6019 mL
10 mM 0.172 mL 0.8602 mL 1.7204 mL 3.4407 mL 4.3009 mL
50 mM 0.0344 mL 0.172 mL 0.3441 mL 0.6881 mL 0.8602 mL
100 mM 0.0172 mL 0.086 mL 0.172 mL 0.3441 mL 0.4301 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on MK-8245 Trifluoroacetate

MK-8245 is a Liver-Targeted Stearoyl-CoA Desaturase (SCD) Inhibitor. MK-8245 is useful for the Treatment of Diabetes and Dyslipidemia.

Featured Products
New Products
 

Description

MK-8245 trifluoroacetate is a liver-targeting inhibitor of stearoyl-CoA desaturase (SCD) with IC50 of 1 nM for human SCD1 and 3 nM for both rat SCD1 and mouse SCD1, with anti-diabetic and anti-dyslipidemic efficacy.

Keywords:

MK-8245 Trifluoroacetate,1415559-41-9,Natural Products,SCD, buy MK-8245 Trifluoroacetate , MK-8245 Trifluoroacetate supplier , purchase MK-8245 Trifluoroacetate , MK-8245 Trifluoroacetate cost , MK-8245 Trifluoroacetate manufacturer , order MK-8245 Trifluoroacetate , high purity MK-8245 Trifluoroacetate

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: